0001209191-24-003230.txt : 20240213
0001209191-24-003230.hdr.sgml : 20240213
20240213185534
ACCESSION NUMBER: 0001209191-24-003230
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240209
FILED AS OF DATE: 20240213
DATE AS OF CHANGE: 20240213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gibson Christopher
CENTRAL INDEX KEY: 0001856369
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40323
FILM NUMBER: 24630909
MAIL ADDRESS:
STREET 1: C/O RECURSION PHARMACEUTICALS
STREET 2: 41 S. RIO GRANDE STREET
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RECURSION PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001601830
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 464099738
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41S RIO GRANDE STREET
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84101
BUSINESS PHONE: (385) 269-0203
MAIL ADDRESS:
STREET 1: 41S RIO GRANDE STREET
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84101
FORMER COMPANY:
FORMER CONFORMED NAME: Recursion Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20140305
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-02-09
0
0001601830
RECURSION PHARMACEUTICALS, INC.
RXRX
0001856369
Gibson Christopher
C/O RECURSION PHARMACEUTICALS
41 S. RIO GRANDE STREET
SALT LAKE CITY
UT
84101
1
1
0
0
Chief Executive Officer
0
Class A Common Stock
2024-02-09
4
A
0
11148
0.00
A
785851
D
Class A Common Stock
2024-02-09
4
A
0
333449
0.00
A
1119300
D
Class A Common Stock
2024-02-09
4
F
0
3233
10.09
D
1116067
D
Stock Option (Right to Buy)
8.55
2033-02-01
Class A Common Stock
0
813600
D
Stock Option (Right to Buy)
11.40
2022-02-04
2032-02-04
Class A Common Stock
0
5436
D
Stock Option (Right to Buy)
11.40
2032-02-04
Class A Common Stock
0
407676
D
Stock Option (Right to Buy)
2.48
2030-12-30
Class A Common Stock
0
343750
D
Class B Common Stock
0.00
Class A Common Stock
0
6471496
D
Class B Common Stock
0.00
Class A Common Stock
0
515000
I
by LAHWRAN-3 LLC
Class B Common Stock
0.00
Class A Common Stock
0
408000
I
by LAHWRAN-4 LLC
Class B Common Stock
0.00
Class A Common Stock
0
118875
I
by Gibson Family Trust
Stock Option (Right to Buy)
10.09
2024-02-09
4
A
0
666898
0.00
A
2034-02-09
Class A Common Stock
666898
666898
D
This RSU vested immediately upon the grant date.
This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2024 and every three months thereafter.
Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
/s/ Jonathan Golightly, attorney-in-fact
2024-02-13